RankAlpha logo
Back to Rankings

CCLD

CareCloudA
Nasdaq / Health Care Equipment & Services
Last Price
Quote time unavailable
View Chart

AI scenario view

RankAlpha Sentiment Codex
B+
Bull case
20%
Probability
Target price
$3.13
Analysis reference price unavailable
Analysis 2026-08-25 · RankAlpha Sentiment Codex
Most likely
B
Base case
55%
Probability
Target price
$2.41
Analysis reference price unavailable
Analysis 2026-08-25 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$1.81
Analysis reference price unavailable
Analysis 2026-08-25 · RankAlpha Sentiment Codex

The current persistence contract does not provide an exact AI reference price. RankAlpha therefore does not calculate scenario return from the live quote. How scenarios are presented

AI sentiment snapshot

Latest data as of 2026-08-25
Recent news sentiment (30D)
+0.2
Mixed
Company
-
Unavailable
Macro
-
Unavailable
Pulse
-
Unavailable
Weekly research (10D)
+30.0
Positive
Sentiment proxy
+80.8
Score

AI commentary

Monitoring-style hold. Sparse recent coverage is directionally constructive on growth, preferred-stock redemption, AI, and Empower, but primary results show weaker year-over-year profitability. Analyst revisions and reliable post-release market reaction are unavailable; missing social, options, short-interest, and employee data reduce confidence rather than provide positive evidence.

RankAlpha Sentiment Codex - 2026-08-25
Open full AI memo

Evidence flagged

No evidence quality warning is currently attached to this memo.

Impact
standard
Confidence
-

AI events

2026-11-23catalystPost-earnings digestion of mixed Q2 resultsMedium impact

Q2 revenue rose 16% year over year to $31.9 million and full-year guidance was reaffirmed, but GAAP net income and adjusted EBITDA declined year over year. This supports monitoring rather than a clean near-term re-rating thesis [#SEC-8K-2026-08-06].

2026-12-31eventSecond-half execution against FY2026 guidanceHigh impact

Delivery of reaffirmed FY2026 revenue guidance of $128-$132 million and adjusted EBITDA guidance of $29-$31 million would validate the growth and margin thesis. Execution depends on converting growth investments into operating leverage [#SEC-8K-2026-08-06].

2027-08-25catalystAI and Empower compliance commercializationHigh impact

CareCloud is investing in AI-enabled offerings and entered compliance and audit defense through the Empower acquisition, creating potential cross-selling across more than 40,000 providers. Commercial conversion and timing remain uncertain [#SEC-8K-2026-08-06].

View full catalyst timeline

Recommendation

N/A

No formal recommendation provided.

Open AI Memo
As of 2026-08-25 • Updated nightlySource: Internal modelMethodology